头孢哌酮-舒巴坦联合加替沙星对重症肺炎患者炎性状态的影响观察  

Observation on the influence of cefoperazone combined with gatifloxacin for the inflammatory state of patients with severe pneumonia

作　　者：吴苏武[1] 赵淑灿[1] 陈伟宏[1] 

机构地区：[1]汕头市中心医院重症医学科,515031

出　　处：《中国现代药物应用》2014年第8期37-38,共2页Chinese Journal of Modern Drug Application

摘　　要：目的：观察头孢哌酮-舒巴坦联合加替沙星对重症肺炎患者炎性状态的影响程度。方法将2012年10月~2013年12月本院的50例重症肺炎患者随机分为对照组（头孢哌酮-舒巴坦组）25例和观察组（头孢哌酮-舒巴坦联合加替沙星组）25例，然后将两组患者治疗前后的血清炎性应激指标进行比较。结果观察组患者治疗后的血清炎性应激指标显著低于对照组患者治疗后及本组治疗前的血清检测结果， P均〈0.05。结论头孢哌酮-舒巴坦联合加替沙星对重症肺炎患者炎性状态的影响程度大于单用头孢哌酮-舒巴坦，因此治疗效果更好。Objective To observe the influence degree of cefoperazone combined with gatifloxacin for the inflammatory state of patients with severe pneumonia.Methods 50 patients with mycoplasma pneumonia in our hospital from October 2012 to December 2013 were randomly divided into control group（cefoperazone group）25 cases and observation group（cefoperazone combined with gatifloxacin group）25 cases, then the serum inflammatory stress indexes of two groups before and and after the treatment were compared.Results The serum inflammatory stress indexes of observation group after the treatment were all lower than those of control group after the treatment and those of observation group before the treatment, allP＆lt;0.05.Conclusion The influence degree of cefoperazone combined with gatifloxacin for the inflammatory state of patients with severe pneumonia is greater than that of only cefoperazone, so the treatment effect is better.

关 键 词：头孢哌酮-舒巴坦 加替沙星 重症肺炎 炎性状态 

分 类 号：R563.1[医药卫生—呼吸系统]